Nobio

Nobio is a biotechnology startup based in Israel with a mission to create a safer and healthier world by eliminating bacteria and viruses from everyday materials and surfaces. The company's innovative technology provides long-term, effective, and non-toxic antimicrobial protection, addressing the limitations of existing solutions. Nobio's product line, Infinix™, offers restorative materials with antibacterial technology, specifically targeting the primary cause of treatment failures in dental care. Beyond its core products, Nobio is actively contributing to the global fight against COVID-19, leveraging its antimicrobial technology to develop protective wear and surface coatings that actively defend against the virus and other pathogens. This initiative aims to safeguard frontline workers and create safer environments in high-risk settings. Notably, Nobio is ISO 13485:2016 certified for the design, development, and manufacturing of medical devices, demonstrating its commitment to quality and compliance. In terms of funding, Nobio secured a $205.00K grant investment from the Israel Innovation Authority in April 2020, showcasing recognition and support from a prominent investor. With its groundbreaking technology and strategic focus on global health challenges, Nobio exemplifies a promising player in the biotechnology sector, poised for significant impact and growth. For more information, interested parties can visit the company's website at www.infinix.com or reach out via the provided contact details.